Syndax Pharmaceuticals (SNDX) Operating Income Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) Operating Income Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.46 Bn | 470.67 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.19 Bn | 115.94 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.44 Bn | 60.69 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 57.08 Bn | 51.90 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 38.11 Bn | 38.11 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.88 Bn | 1.53 Bn | 53.02 Mn | 59.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.17% |
| Dec 31, 2025 | 35.09% |
| Sep 30, 2025 | 35.89% |
| Jun 30, 2025 | 6.55% |
| Mar 31, 2025 | -5.34% |
| Dec 31, 2024 | -23.70% |
| Sep 30, 2024 | -58.95% |
| Jun 30, 2024 | -49.39% |
| Mar 31, 2024 | -72.80% |
| Dec 31, 2023 | -85.34% |
| Sep 30, 2023 | -60.37% |
| Jun 30, 2023 | -31.69% |
| Mar 31, 2023 | -24.84% |
| Dec 31, 2022 | -143.90% |
| Sep 30, 2022 | -75.42% |
| Jun 30, 2022 | -68.91% |
| Mar 31, 2022 | -35.69% |
| Dec 31, 2021 | 582.12% |
| Sep 30, 2021 | -0.90% |
| Jun 30, 2021 | -34.46% |